Integra LifeSciences
IART
204 hedge funds and large institutions have $919M invested in Integra LifeSciences in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 76 reducing their positions, and 33 closing their positions.
1.44% more ownership
Funds ownership: 93.5% → 94.94% (+1.4%)
3% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 33
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 207 → 204 (-3)
11% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 76
12% less capital invested
Capital invested by funds: $1.04B → $919M (-$125M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QCM
Quantinno Capital Management
New York
|
+$8M |
| 2 |
Neuberger Berman Group
New York
|
+$7.21M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$6.17M |
| 4 |
SG Americas Securities
New York
|
+$5.06M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$3.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$20.6M |
| 2 |
DM
Deerfield Management
New York
|
-$10M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$3.7M |
| 4 |
SPS
Susquehanna Portfolio Strategies
Bala Cynwyd,
Pennsylvania
|
-$2.62M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.42M |
IART Hedge Fund Activity: Q4 2025 in Review
204 of the 8,264 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2025, worth a combined $919M — down 12% from $1.04B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new IART positions and 33 closed out — a net gain of 1 holder — while 68 added to existing stakes and 76 trimmed.
The largest buyer was Quantinno Capital Management, adding an estimated $8M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $20.6M sold.
- 204 institutional investors held Integra LifeSciences (IART) as of Q4 2025, down from 207 in Q3 2025.
- Funds reported $919M of Integra LifeSciences stock for Q4 2025, down 12% quarter-over-quarter.
- 34 funds opened new Integra LifeSciences positions in Q4 2025 and 33 closed out, a net change of +1 holder.
- The largest Integra LifeSciences buyer in Q4 2025 was Quantinno Capital Management, an estimated $8M added.
- The largest Integra LifeSciences seller in Q4 2025 was Soleus Capital Management, an estimated $20.6M sold.
Based on aggregated 13F filings for Q4 2025.